An alternative liquid-driven pumpless micromixer for efficient therapy encapsulation in lipid-based nanoparticles

Our project focuses on developing a new device to create nanosized particles called lipid-based nanoparticles (LBNs) that can carry substances like genes, drugs, and proteins. LBNs have been successful in COVID vaccines and cancer treatments, but developing these therapies is challenging and requires specialized knowledge and equipment. To address this, we aim to create a device that can make LBNs without the need for expensive pumps, aided by alternative methods to drive fluids. The collaboration with the partner organization will accelerate the transformation of our academic solution into a commercial product, while also enhancing Innovations Galilei 2 (V1 studio)’s reputation and ability to support other promising projects. In summary, our project aims to revolutionize LBNs production, and through the partnership with Innovations Galilei 2 (V1 studio), we will have the opportunity to develop a business idea.

Faculty Supervisor:

Effrosyni Diamantoudi;Christine DeWolf;Christine DeWolf

Student:

Partner:

V1 Studio;Nanofacile

Discipline:

Life Sciences

Sector:

Education

University:

Concordia University

Program: